Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine

NCT03527355 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

285

Enrollment

OTHER

Sponsor class

Conditions

Typhoid

Interventions

BIOLOGICAL: Vi-DT
BIOLOGICAL: FluQuadri™
OTHER: 0.9% sodium chloride isotonic solution

Sponsor

International Vaccine Institute

Collaborators

[object Object]
[object Object]